Cyclacel Pharmaceuticals ...

NASDAQ: CYCC · Real-Time Price · USD
8.21
-0.68 (-7.65%)
At close: Aug 15, 2025, 1:27 PM

Cyclacel Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-66.85 -22.66 -84.96 -441
PEG Ratio
0.70 -37.99 7.58 -2.9
PS Ratio
17.43K 1.22K n/a n/a
PB Ratio
-344.75 842.04 88.14 220.97
P/FCF Ratio
-93.8 -31.71 -86.44 -448.6
P/OCF Ratio
-93.8 -31.72 -86.47 -449.25
OCF/S Ratio
-185.81 -38.36 n/a n/a
Debt / Equity Ratio
n/a 0.06 0.01 0.00
Quick Ratio
0.59 0.91 3.25 7.46
Current Ratio
0.59 0.91 3.25 7.56
Asset Turnover
0.01 0.05 n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
5.16 -37.16 -1.04 -0.5
Return on Assets
-2.74 -2.56 -0.76 -0.44
Return on Invested Capital
5.16 -34.89 -1.1 -0.51
Dividend Yield
n/a 0.00 0.00 0.00
Payout Ratio
n/a -0.01 -0.01 -0.01
Gross Profit Margin
1.00 1.00 n/a n/a
Net Profit Margin
-260.74 -53.7 n/a n/a
Pretax Profit Margin
-278.93 -60.84 n/a n/a
Operating Profit Margin
-279.16 -60.6 n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-279.02 -60.53 n/a n/a